Cost is usually the first practical question that comes up once someone decides Spravato (esketamine) might be worth trying for treatment-resistant depression. The honest answer is that it depends almost entirely on your insurance, not your location. Whether you’re covered through a commercial plan, Medicare, or Medicaid changes the price significantly. Here’s a realistic breakdown of what to expect.
| Scenario | Typical Cost |
|---|---|
| Commercial insurance, with copay card | As low as $10 per session |
| Commercial insurance, without copay assistance | Roughly $0 to $250 per session, depending on your plan |
| Medicare (Part B), approved | Standard Part B cost-sharing applies |
| Medicaid (including CareSource), approved | Little to no out-of-pocket cost |
Those figures are national averages, and clinic billing practices can shift them a bit in either direction. The bigger factor by far is which of the paths below applies to you.
What Actually Drives the Cost
Spravato billing has two separate parts: the medication itself and the required in-clinic monitoring. Because Spravato carries a risk of sedation and dissociation, federal REMS rules require patients to be observed for at least two hours after every dose, and that supervision is billed separately from the drug. Both pieces have to be covered for your cost to stay low, which is part of why prior authorization matters so much. This also explains why the first month costs more than later months: the standard induction schedule involves two sessions per week for about four weeks, so you’re accumulating twice as many copays or coinsurance charges as you will during maintenance.
Cost With Commercial Insurance
Because Spravato is FDA-approved for treatment-resistant depression, most commercial insurance plans cover it once prior authorization is approved. Approval generally hinges on documentation that you’ve tried and not responded adequately to other antidepressants, so your provider’s notes on your treatment history do a lot of the work here.
Johnson & Johnson, the manufacturer, also offers a copay assistance program that can bring the medication cost down to as little as $10 per treatment for eligible, commercially insured patients. It’s worth knowing upfront that this particular copay card is generally not usable if you have Medicare or Medicaid, since manufacturer copay assistance programs are typically restricted to commercial insurance by federal rules. Without the copay card, what you pay depends on your plan’s specifics: whether you’ve met your deductible, whether the clinic is in network, and whether Spravato is billed through your medical benefit or your pharmacy benefit.
Cost With Medicare
Medicare covers Spravato under Part B for patients who meet the clinical criteria, since it’s administered in a clinical setting rather than dispensed for home use. That means standard Part B cost-sharing applies: after your annual deductible, you’re generally responsible for a percentage of the approved amount for both the medication and the monitoring.
If you carry a Medigap policy or are enrolled in a Medicare Advantage plan, your actual out-of-pocket cost may be lower, though Advantage plans often have their own prior authorization requirements and network rules. Because Medicare patients aren’t eligible for the manufacturer’s copay card, it’s worth asking your clinic what your supplemental coverage will actually pick up before you start.
Cost With Medicaid
Ohio Medicaid, including CareSource, covers Spravato, but only after prior authorization is approved based on documented treatment history. We’ve written in detail about exactly what CareSource requires for approval in our post on whether Medicaid covers Spravato in Ohio, including the specific documentation your provider needs to submit.
Once approved, Medicaid patients typically have little to no out-of-pocket cost for either the medication or the required monitoring visits, since Medicaid rules limit how much can be charged in copays for covered services. The main variable for Medicaid patients isn’t price, it’s approval, which makes getting the prior authorization right the first time the most important step.
| Insurance Type | What’s Typically Required | Typical Out-of-Pocket Cost |
|---|---|---|
| Commercial insurance | Prior authorization; copay card eligibility | $10 to $250 per session |
| Medicare (Part B) | Documented treatment-resistant depression | Standard Part B cost-sharing applies |
| Medicare Advantage | Plan-specific prior authorization and network rules | Varies by plan |
| Ohio Medicaid (e.g., CareSource) | Prior authorization with documented antidepressant trial history | Little to none, once approved |
Why Prices Vary by Clinic
Even within the same insurance category, the exact number you’re quoted can differ from one clinic to another. Facility fees, how monitoring time is billed, whether the clinic is in network with your plan, and whether Spravato is billed through the medical benefit versus the pharmacy benefit can all shift the final number. This is why it’s worth asking any clinic you’re considering for a clear, itemized estimate based on your actual plan rather than a general quote.
Financial Assistance Options
Beyond your plan’s coverage, a couple of additional resources can help lower costs:
- The manufacturer’s SPRAVATO withMe savings program, for commercially insured patients
- Payment plans offered directly through some treatment clinics to spread out deductible or coinsurance costs
A good clinic will walk you through which of these actually apply to your situation rather than leaving you to piece it together on your own.
How EverHope Handles Cost and Insurance Verification
At EverHope Wellness Center, our team verifies your specific benefits and handles the prior authorization process before your first dose, so you have a clear picture of your actual out-of-pocket cost ahead of time rather than finding out after a session. If you’re weighing Spravato against other options, our post comparing Spravato and ketamine also covers how insurance coverage differs between the two, since that’s often a deciding factor for patients on a budget.
Common Questions About Spravato Cost
Does having Medicaid guarantee low-cost Spravato treatment?
Not automatically. Medicaid, including CareSource, requires prior authorization based on documented treatment history before it will cover Spravato. Once approved, though, out-of-pocket costs are typically minimal.
Is the $10 copay program available to everyone?
No. The manufacturer’s copay assistance program is generally limited to patients with commercial insurance. Patients with Medicare or Medicaid are usually not eligible for that specific program, though other cost-sharing protections apply to those plans instead.
Does the cost of Spravato include the office visit?
It should. Because the required monitoring period is part of REMS compliance, most clinics bill the observation time as part of the overall treatment cost rather than as a separate, unrelated office visit.
Why does the first month cost more than later months?
The standard induction schedule calls for two doses per week for about four weeks, which is more frequent than the once-weekly or biweekly maintenance schedule most patients move to afterward. More sessions in a shorter window means more copays or coinsurance charges upfront.
What happens if my prior authorization is denied?
A denial usually comes down to missing documentation rather than a final “no.” Most plans allow an appeal, and providing a more complete record of previous antidepressant trials and outcomes often resolves it. Your clinic should handle the resubmission on your behalf.
Ready to Find Out Your Actual Cost? EverHope Wellness Center Can Help
The only way to know your real cost is to have your specific insurance verified and a prior authorization submitted on your behalf. Our team at EverHope Wellness Center in Delaware, Ohio can walk you through exactly what to expect before you commit to treatment.
